Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tailored H. pylori eradication based on 23S rRNA mutation (EHR)
NCT02761005Phase 2Unknown
- Sponsor
- Hamamatsu University School of Medicine
- Start
- May 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vonoprazan in Helicobacter pylori infection, sponsored by Hamamatsu University School of Medicine. Status: unknown.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02761005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02761005.